ABSTRACT Isatin‐based ligands have been recognized for their remarkable pharmacological potential and this study reports the synthesis, characterization, and biological evaluation of three novel nickel(II)‐isatin hydrazone complexes ( C1–C3 ). The complexes were characterized by FT‐IR, UV–vis, mass spectroscopy, DFT, magnetic, conductivity and thermal analyses indicating octahedral geometry and appreciable heat stability. Molecular electrostatic potential mapping gave information on their electronic properties. DFT calculations indicated decreased HOMO–LUMO gaps indicating increased reactivity. Biological screening showed remarkable anticancer activity against HCT‐116, A549, MCF‐7, and HepG‐2 cell lines (IC 50 = 7.22–17.33 µM), potent antibacterial and antifungal activities comparable to ciprofloxacin and clotrimazole against Staphylococcus aureus and Candida albicans , and significant antioxidant activity with 59%–69% of the radical scavenging. Molecular docking and dynamics studies showed the stable binding interactions with the target enzyme FabH especially for complex C3 . These results collectively highlight C1‐C3 as multifunctional therapeutic candidates with stability and reactivity properties, making them attractive scaffolds for pharmacological development.
Background/Objectives: Repurposing existing drugs may represent a promising strategy for effective cancer therapy. This study was the first to investigate the augmented antitumor therapeutic effect achieved by co-incorporating the NSAID Niflumic acid (NIF) with ceramides into PEGylated cerosomes (NIF-loaded PEG-CERs) in a novel platform that targets specifically the MAPK-ERK signaling pathway and miR-21-5p modulation. Methods: The prepared formulae were statistically optimized utilizing a full factorial design and the optimal formula (C5) was further incorporated into a topical gel and evaluated for ex vivo rat skin permeation, and tested in vivo in a subcutaneous solid Ehrlich carcinoma (SEC) mice model. Results: The optimal formula (C5) showed tubular elongated morphology with higher EE% (96.71 ± 0.0), lower vesicular size (VS) and PDI values, 292.95 ± 0.78 nm and 0.47 ± 0.0 respectively. A high ZP value (−37.5 ± 0.57 mV) was in accordance with stability results showing good stability of the optimal formula (C5). Permeability studies exhibited 2.02-fold higher skin permeation compared to pure NIF gel. A significant decrease in tumor volume and marked improvement in survival rate in SEC mice were confirmed by downregulation of EGFR, ERK1, ERK2, and miR-21-5p expression. Furthermore, an increase in total antioxidant capacity and caspase-3 levels was observed, accompanied by significant suppression in cyclin D1, MMP-2, COX-2, and MDA levels. Finally, histopathological analysis revealed the superior antitumor effect of C5 gel together with immunohistochemical assay showing the lowest BCL-2-positive staining, indicating the restoration of physiological apoptotic balance. Conclusions: Based on the previous findings, NIF-loaded PEG-CERs offer augmented therapeutic potential for efficient topical skin cancer management in an SEC mice model.
Bio-based solutions are becoming more and more important in the shift to global sustainability. Sustainable microbiology becomes a crucial field that connects the Sustainable Development Goals (SDGs) of the UN with molecular mechanisms. The many functions of microorganisms as functional drivers of the 2030 Agenda are critically assessed in this review, which goes beyond the conventional view of them as pathogens to consider them as “biological infrastructure.” The development of biopesticides for food security (SDG 2), the engineering of exoelectrogenic biofilms for clean energy (SDG 7), and the optimization of metabolic flux in circular bioeconomies (SDG 12) are just a few of the major SDGs for which we examined the integration of microbial processes. “Structural Biotechnology,” where microbes help create self-healing urban environments (SDG 11) and act as carbon-sequestering allies in mitigating climate feedback loops (SDG 13), was given particular attention. This report also addressed the “Biotech Divide,” arguing that in order to achieve SDGs 10 (Reduced Inequalities) and 16 (Peace and Justice), biological infrastructure protection and fair access to genomic surveillance were essential in areas affected by conflict. Our results highlight the importance of maintaining microbial diversity for human health and economic resilience, rather than just as an environmental objective. The review concludes that interdisciplinary collaborations (SDG 17) that convert laboratory-scale bioprocesses into scalable, worldwide sustainability solutions are the only way to fully realize the potential of microbiology.
Sustainable Development Goalsbiopesticidesfood securityclean energy
Abstract Enterobacter cloacae is infrequently reported in milk samples and bovine mastitis. Here we report for the first time, the detection and phylogenomic analysis of an Enterobacter cloacae strain isolated from a raw milk sample obtained from a clinical mastitis-infected cow in Bangladesh using whole genome sequence analyses. Enterobacter cloacae strain BRMHR107Ecl belonged to sequence type ST84, belonging to a rarely reported ST in the Enterobacter genus. Phylogenomic analyses revealed that the strain is closely related to a strain previously isolated in Bangladesh. The closest relative to BR-MHR107Ecl was a strain isolated in 2016 from a human rectal swab sample in Nigeria. The BR-MHR107Ecl strain co-harbored beta-lactamase genes including bla DHA-1 and bla CMH-3-like . Other antimicrobial resistance genes were detected and included aminoglycoside resistance genes ( aph(3″)-Ib-like, aph(6)-Id ), fluoroquinolone resistance gene ( qnr B4) and sulphonamide resistance gene ( sul 1). The genome harbored an additional disinfectant resistance gene ( qacE -like). Several plasmid replicons, including Col(pHAD28), IncFIA(HI1), IncFIB(K), IncR, and repB(R1701) were detected. Virulence genes encoding for heat-stable enterotoxin EAST-1 ( astA ) and lipoprotein NlpI precursor ( nlpI ) were detected. The multidrug resistance and virulence genes repertoire of BR-MHR107Ecl and its isolation from bovine mastitis milk render it a potentially significant public health concern, highlighting its emerging threat to dairy herds and underscoring the importance of genomic surveillance in food animals and non-clinical environment to detect emerging pathogens. This study will contribute to understanding the transmission of E. cloacae from farm-to-fork which requires collaborative and comprehensive One health approaches. The findings will help monitor the global dissemination of antimicrobial resistance in livestock-associated Enterobacter cloacae in the One Health context.
Frontiers in Pharmacology · مجلد 16 · 1595177-1595177
Background Albendazole (ALB), originally developed as an anthelmintic agent, has been repurposed for use in cancer therapy. In the present work, ALB was incorporated into stearyl amine (SA)-based elastic cerosomes (EC) to improve its anticancer activity. Methods Stearyl amine elastic cerosomes containing albendazole (SA-EC-ALB) were formulated using the thin-film hydration method. A D-optimal experimental design was applied via Design-Expert® software (version 7) generating 19 formulations. The independent variables included SAA amount (X1), sonication time (X2), ceramide type (X3), and SAA type (X4), while the dependent variables were entrapment efficiency (EE%; Y1), particle size (PS; Y2), and polydispersity index (PDI; Y3). Results The optimized SA-EC-ALB formulation, prepared with ceramide III and Pluronic L121 through sonication, achieved an entrapment efficiency (EE%) of 92.03 ± 3.53% and a particle size (PS) of 312.05 ± 9.32 nm. In-silico analysis indicated strong interactions between ALB and the vesicular components in water. Moreover, in-vivo evaluation of SA-EC-ALB antitumor activity, performed using the solid Ehrlich tumor model in adult Swiss albino male mice, demonstrated a significant reduction in tumor volume compared to the control group. Conclusion Loading ALB into SA-EC could potentially induce its anticancer effects.
Background: Migraine, a complex neurological condition, poses significant challenges for both sufferers and healthcare providers. While prescription medications play a vital role in managing migraine attacks, the quest for natural, non-pharmacological alternatives has garnered increasing interest. This review explores the efficacy and safety of natural supplements as treatments for migraine relief, comparing them with conventional prescription medications. Methods: The review delves into herbal supplements, clinical studies on natural remedies, aromatherapy, dietary influences, and lifestyle modifications in the context of migraine management in several databases. Results: The findings shed light on the potential of natural supplements as complementary or alternative approaches to traditional migraine therapies, offering insights into a holistic and personalized treatment paradigm for migraine sufferers. Conclusions: Natural supplements have gained attention as potential treatments for migraine relief, often perceived as safer alternatives to conventional medications.